期刊文献+

碳青霉烯耐药菌的耐药机制研究进展 被引量:1

Advances in the Mechanism of Carbapenem-Resistant Bacteria
原文传递
导出
摘要 碳青霉烯类抗生素自一出现就表现出较广的抗菌谱和较强的抗菌活性,由于其对β-内酰胺酶稳定,引起研究人员广泛的关注,至今对该化合物的研究已取得了很大的进展。文章主要从产β-内酰胺酶、膜通透性降低、主动外排泵的亢进以及作用靶位的改变等4个方面讨论了碳青霉烯类耐药菌的耐药机制。碳青霉烯类抗生素在临床上应用广泛,该类化合物的耐药细菌也越来越多。在复杂的耐药机制背景下,探索相关耐药机制将有助于加速发现更有效的化合物。 After the clinical application of carbapenem antibiotics, they had demonstrated a broad-antibacterial- spectrum and strong antibacterial activity; besides, they were stable to various β-lactamases discovered. So they had attracted a great attension of research scientists on studying their characteristics and clinical potentials. In order to develop carbapenem antibiotics with higher antimierobial activity, different mechanisms of the carbapenem-resistant bacteria had been discussed. Up to date, considerable progress on this anti- biotic had been achieved. In this review ,the production of β-lactamase ,loss of oprin,overproduction of efflux pumps and the change of the target site were discussed and summarized in mechanism of carbapenem-resistant bacteria. The bacterial resistance of carbap- enem antibiotics,which were widely used in clinic, had been more and more serious. The drug resistance mechanism of carbapenem antibiotics also became more and more complex, and exploration of the resistance mechanism of drug-resistant bacteria could be used to speed the discovery of more effective compounds.
出处 《药物生物技术》 CAS 2013年第4期373-376,共4页 Pharmaceutical Biotechnology
关键词 耐碳青霉烯 机制 Β-内酰胺酶 Carbapenem-resistantance Mechanism β-Lactamase
  • 相关文献

参考文献23

  • 1Cejas D, Canigia L F, Nastro M, et al. Hyperendemic clone of KPC producing Klebsiella pneumoniae ST 258 in Buenos Aires hospitals [ J 3. Infection Genetics Evolution ,2012,12 ( 3 ) :499.
  • 2Virglncar N, Iyer S, Stacey A, et al. Klebsiella pneumoniae produ- cing KPC carbapenemase in a district general hospital in the UK [ J]. Journal Hospital Infection,2011,75(4) :293.
  • 3Leao R S,Pereira R H V,Folescu T W,et al. KPC-2 Carbapene- mase-producing Klebsiella pneumoniae isolates from patients with Cystic Fibrosis[ Jl. Journal Cystic Fibrosis,2011,10(2) :140.
  • 4Leavitt A, Navon-Venezia S, Ghmelnitsky I, et al. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an israeli hospital [ J ]. Antimicrob Agent Chemother, 2007,51 ( 8 ) : 3026.
  • 5Villequs M V, Lolans K, Correa A, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapen- em-hydrolyzing 13-1actamase [ J ] Antimicrob Agent Chemother, 2007,51(5) :1553.
  • 6汤瑾,蒋燕群,李卿,王坚镪.一例碳青霉烯类抗菌药物耐药的肺炎克雷伯菌耐药机制研究[J].检验医学,2009,24(5):343-346. 被引量:17
  • 7Nitsara B, Phannarai P, Class 1 integron containing metallo -13- lactamase gene blaiipq in carbapenem-resistant Pseudomonas aeruginosa in Thailand [ J ]. J Infect Chernother, 2009, 15 (4) :257.
  • 8Khosravi Y, Tay S T, Vadivelu J. Metallo-13-1actamase-producingi- mipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11 [ J ]. Diagnostic Microbiology Infectious Disease, 2010,67 ( 3 ) : 294.
  • 9Lauretti L, Riccio M L, Mazzariol A, et al. Cloning and character- ization of blavlM, a new integron-bome metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate[ J ]. Antimi- crob Agents Chemother, 1999,43 (7) : 1584.
  • 10Van der Bij A K, Van Mansfeld M, Peirano G, et al. First outbreak of VIM-2 metallo-13-1actamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes[ J ]. Inter J Antimicrobial Agents,2012,37 (6) :513.

二级参考文献44

  • 1张永,唐英春,陆坚,张扣兴.鲍曼不动杆菌对亚胺培南耐药分子机制的研究[J].中国抗生素杂志,2005,30(4):217-221. 被引量:71
  • 2王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 3宗志勇,雷秉钧,吕晓菊,高燕渝,俞汝佳.鲍曼不动杆菌耐药性和金属β内酰胺酶的检测[J].中华检验医学杂志,2005,28(10):999-1001. 被引量:23
  • 4王辉,陈民钧,倪语星,陈冬梅,孙自庸,陈燕,赵旺胜,邹雄,俞云松,胡志东,黄心宏,徐英春,谢秀丽,褚云卓,王倩,梅亚宁,田彬,张蓓,孔庆莲,于秀娟,潘玉红.2003—2004年中国十家教学医院革兰阴性杆菌的耐药分析[J].中华检验医学杂志,2005,28(12):1295-1303. 被引量:236
  • 5赵旺胜,童光萍,周小玉,洪立基.96株临床分离细菌对泰能的敏感性分析[J].南京医科大学学报(自然科学版),1996,16(6):584-584. 被引量:4
  • 6Leavitt A, Navon-Venezia S, Chmelnitsky I,et al. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an israeli hospital[J]. Antimicrob Agent Chemother, 2iX)7, 51(8):3026-3029.
  • 7Yiqit H,Queenan AM,Anderson G,et al. Novel carbap- enem-hydrolyzing β-lactamase KPC-1 from a carbapenem-resistant strain of Klebsiella pneumon/ae [ J ]. Antimicrob Agent Chemother, 2001, 45(4):1151-1161.
  • 8Miriagou V,Tzouvelekis LS,Rossiter S, et al. Imipenem resistance in a Sa/monel/a clinical strain due to plasmid- mediated class A carbapenemase KPC-2 [ J ]. Antimicrob Agent Chemother, 2003, 47(4) : 1297-1300.
  • 9Yiqit H,Queenan AM,Rasheed JK, et al. Carbapenemresistant strain of KZebsiella oxytoca harboring carbapenem-hydrolyzing bota-lactamase KPC-2 [ J ]. Antimicrob Agent Chemother, 2003, 47(12):3881-3889.
  • 10Wei ZQ, Du XX,Yu YS,et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China[J]. Antimicrob Agent Chemother, 2007, 51(2):763-765.

共引文献217

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部